Chemical Component Summary

Name2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-yl-thieno[3,2-d]pyrimidine
Identifiers2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-yl-thieno[2,3-e]pyrimidine
FormulaC23 H27 N7 O3 S2
Molecular Weight513.636
TypeNON-POLYMER
Isomeric SMILESCS(=O)(=O)N1CCN(CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4cn[nH]5)N6CCOCC6
InChIInChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)
InChIKeyLHNIIDJUOCFXAP-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count62
Chiral Atom Count0
Bond Count67
Aromatic Bond Count21

Drug Info: DrugBank

DrugBank IDDB11663 
NamePictilisib
Groups investigational
DescriptionPictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Solid Cancers, among others.
SynonymsPictilisib
Categories
  • Amides
  • Heterocyclic Compounds, Fused-Ring
  • Phosphatidylinositol 3-Kinases, antagonists & inhibitors
  • Pyrazoles
  • Sulfones
CAS number957054-30-7

Related Resource References

Resource NameReference
Pharos CHEMBL521851
PubChem 17755052
ChEMBL CHEMBL521851
ChEBI CHEBI:65326